ICLC Research

The International Consortium for Low-Grade Serous Ovarian Cancer (ICLC) brings together a broad range of low-grade serous carcinoma research expertise from Australia, America, Canada, Europe, New Zealand and the United Kingdom. By working collaboratively, the ICLC can leverage decades of knowledge, laboratory resources, and patient connections for the benefit of the tens of thousands of women living with low-grade serous carcinoma. The goal of the ICLC is to improve the survival and quality of life for women with low-grade serous carcinoma by developing novel therapeutics.